VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1652032
Sex: F
Age:
State:

Vax Date: 05/07/2021
Onset Date: 05/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: 1 week after had menstrual cycle out of cycle; 7 days of heavy menstrual cycle; severe mood swings from crying to anger, very uncharacteristic; Lathergic and need to take several naps throughout day to function.; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07May2021 at 13:15 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications included gliclazide (CLARITIN), rubus idaeus leaf, sambucus nigra flower, sambucus nigra fruit (ELDERBERRY), mometasone furoate (ASMANEX), ketoprofen (TOP), cyanocobalamin, pyridoxine hydrochloride, thiamine hydrochloride (SUPER B) and fish oil (OMEGA 3); all for unspecified indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 13May2021, the patient experienced 1 week after had menstrual cycle out of cycle, heavy cycle when normally it was light. Normal cycle lasted only 3-4 days, but (cycle started on 13May2021) was approaching 7 days of constant bleeding. The patient also experienced out of normal severe mood swings from crying to anger, very uncharacteristic and also felt lethargic and needed to take several naps throughout day to function. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event 1 week after had menstrual cycle out of cycle, heavy cycle when normally it was light, normal cycle lasted only 3-4 days, but (cycle started on 13May2021) was approaching 7 days of constant bleeding, out of normal severe mood swings from crying to anger, very uncharacteristic and lethargic and needed to take several naps throughout day to function was not recovered at the time of reporting. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: CLARITIN [GLICLAZIDE]; ELDERBERRY [RUBUS IDAEUS LEAF;SAMBUCUS NIGRA FLOWER;SAMBUCUS NIGRA FRUIT]; ASMANEX; TOP [KETOPROFEN]; SUPER B [CYANOCOBALAMIN;PYRIDOXINE HYDROCHLORIDE;THIAMINE HYDROCHLORIDE]; OMEGA 3 [FISH OIL]

Current Illness:

ID: 1652033
Sex: F
Age:
State: PA

Vax Date: 05/17/2021
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: mild headache all day; body aches developed throughout the day; drenched in sweat; vomited; This is a spontaneous report from a contactable other healthcare professional, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 17May2021 at 15:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, high cholesterol. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (PROZAC); all for an unknown indication from an unknown date. The patient previously took Reglan, Tetanus and Ceftin on an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 26Apr2021 at 17:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18May2021, the morning after the 2nd vaccine the patient had a mild headache all day, body aches developed throughout the day, she woke up at midnight drenched in sweat and vomited. The adverse events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. The patient did not receive any treatment for the events. The clinical outcome of the events body aches developed throughout the day, drenched in sweat, mild headache all day and vomited was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: LISINOPRIL; ATORVASTATIN; PROZAC

Current Illness:

ID: 1652034
Sex: M
Age:
State:

Vax Date: 04/17/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Tiredness; Muscle pain; sour; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731), via an unspecified route of administration on 17Apr2021 (at the age of 27-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient had a history of allergy to broad bean and bezoar. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Apr2021, the patient experienced tiredness, muscle pain and sour. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tiredness, muscle pain and sour was resolved on an unknown date in 2021. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182), via an unspecified route of administration on 08May2021 (at the age of 27-year-old), as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652035
Sex: M
Age:
State: AL

Vax Date: 01/12/2021
Onset Date: 02/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: Test Date: 202102; Test Name: IgG level; Result Unstructured Data: Test Result:Very low; Comments: Quantitative IgG level was very low

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: quantitative IgG level was very low; This is a spontaneous report from a contactable physician, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH9899) via intramuscular route of administration in the left arm on 12Jan2021 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis. The patient had no allergies to medications, food, or other products. Concomitant medications included ustekinumab (STELARA) taken from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 21Dec2020 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Feb2021, one month after the second dose, the patient experienced that his quantitative Immunoglobulin G (IgG) level was very low. He feared whether Stelara had blunted the dose and if he had been fully vaccinated. The patient was still practicing medicine and at a risk for COVID, so he wondered if he can hold his Stelara and get a booster and he was willing to do it as research if needed. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event low quantitative IgG level was resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: STELARA

Current Illness:

ID: 1652036
Sex: M
Age:
State: AZ

Vax Date: 01/15/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202104; Test Name: Lab. Work; Result Unstructured Data: Test Result:Unknown results; Comments: Lab. Work: Consumer stated, "Had a month ago; Test Name: Weight; Result Unstructured Data: Test Result:180 lbs; Comments: 180 Pounds or so

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Ringing in ears; Pumping like a heartbeat in my ears like they say the heart is in your ears; Sensitive to sunlight and sensitive to sounds.; Sensitive to sunlight and sensitive to sounds.; Kind of cloudiness, fogginess in my thinking; This is a spontaneous report from a contactable consumer. A 54-year-old male patient received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an unspecified route of administration on 15Jan2021 (Batch/Lot Number: EL3249) as DOSE 1, SINGLE; dose 2 via an unspecified route of administration on 05Feb2021 (Batch/Lot Number: EL9264) as DOSE 2, SINGLE for covid-19 immunisation. The patient's Medical history included Ongoing Paget's disease. The patient's Concomitant medication included zoledronic acid (RECLAST), via unspecified route of administration from unknown date to unknown date at unknown dose and frequency for an unspecified indication. On an unknown date patient experienced ringing in ears; pumping like a heartbeat in my ears like they say the heart is in your ears; sensitive to sunlight and sensitive to sounds; kind of cloudiness, fogginess in my thinking. Consumer stated, "I got this number from somebody to call to see if there was any side effects to the Pfizer Vaccine for the Covid (Confirmed as Pfizer Covid- 19 Vaccine).To see if there was any side effects that I am having that are related or may be other are experiencing? Or if there are a lot of other people are experiencing the same thing may be its common thing. I just do not know just trying to get to the bottom of what is going on with me?" Consumer was informed about the role of Pfizer Drug Safety Department. Consumer further stated, "I am having some, I am hearing some ringing in my ears and there is also some kind of a pumping like a heartbeat in my ears like they say the heart is in your ears, like the beat and also I am having some sensitivity to the different bright light, things are really bright like the sunlight and sensitive to sounds. So, brightness in eyes and sensitive to sounds took part of the something ringing in the ear is something that may be something that is medium loud, not even loud even kids like laughing and screaming that too is sensitive and another thing is I guess is I do not know just a kind of little foggy, kind of cloudiness, fogginess in my thinking I guess." Treatment: Consumer stated, "I went to the two different ENT's for the ear problem. I went to an eye doctor too. I went to three different eye Doctors." Second Dose of Covid -19 vaccine administered on: Consumer stated, "05Feb" Expiration date of first dose of Pfizer Covid-19 Vaccine: Consumer stated, "I do not know what is the expiration date. Do not have on my card." LOT# (Second dose): Consumer stated, "EL9264." Expiration date: Consumer stated, "My card does not have that. It just has the lot number and the date of administration." Weight: Consumer stated, "180 Pounds or so." Lab. Work: Consumer stated, "Had a month ago (Further clarification hence not checked)". The outcome for the events was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds: RECLAST

Current Illness: Paget's disease

ID: 1652037
Sex: F
Age:
State: TN

Vax Date: 05/17/2021
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: fever more than 24 hours after shot; chills; body aches; lethargy; This is a spontaneous report from a non-contactable healthcare professional. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17May2021 at 14:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medication included birth control (unspecified); taken for an unknown indication from an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18May2021 at 05:00, the patient experienced fever more than 24 hours after shot, chills, body aches and lethargy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever more than 24 hours after shot, chill, body aches and lethargy was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652038
Sex: F
Age:
State: CA

Vax Date: 05/14/2021
Onset Date: 05/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Very sore shoulder; Very sore shoulder and upper left back; spreading all the way to left breast; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0185) via an unspecified route of administration in the left arm on 14May2021 at 13:45 (at the age of 48-year-old) as a single dose for COVID-19immunisation.The patient did not have any relevant medical history. The patient did not receive any medication within two weeks of vaccination. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0172) via an unspecified route of administration in the left arm on 23Apr2021 at 15:45 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07May2021, the patient experienced very sore shoulder and upper left back spreading all the way to left breast. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events very sore shoulder and upper left back spreading all the way to left breast was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652039
Sex: U
Age:
State:

Vax Date: 05/05/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Mouth sore; throat sores; persistent cough; This is a spontaneous report from a non-contactable consumer, the patient. A unknown gender patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration on 05May2021 at 00:00, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 01:00, the patient experienced mouth sore, throat sore and persistent cough. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of adverse events. The clinical outcome of the events mouth sore, throat sore and persistent cough were not recovered at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652040
Sex: F
Age:
State: NY

Vax Date: 05/04/2021
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Menstrual cycle was late by 8 day; painful cramps; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 13:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included levothyroxine sodium (UNITHROID) and colecalciferol (VITAMIN D3) all from unknown date, for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 13Apr2021 at 13:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18May2021 at 07:00 the patient reported that menstrual cycle was late by 8 day, when it did start, it was accompanied by painful cramps, which was not normal for her. She usually did not have cramps with her cycle. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as the result of adverse events and included treatment with MOTRIN. The clinical outcome of the events delayed menstrual cycle and painful cramps were recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: UNITHROID; VITAMIN D3

Current Illness:

ID: 1652041
Sex: F
Age:
State: OR

Vax Date: 05/14/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: limited appetite for various food; This is a spontaneous report from a contactable Other health care professional (Patient). A 62-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/Lot Number: EW0186), via an unspecified route of administration on 14May2021 at 16:15 (age at vaccination 62-years-old) as dose 2, single for covid-19 immunization. Medical history included hypertension and patient was allergic to penicillin, statin, sulfa, latex and hypertension. Concomitant medications within two weeks included blood pressure medicine + statin. There were no other vaccine within 4 weeks. The patient did not had Covid prior vaccination and did not test for Covid post vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 23Apr2021 at 16:30 (Batch/Lot Number: EW0172) as dose 1, single for covid-19 immunization and experienced hypersomnia. On 15May2021 at 13:00, after second vaccination, the patient experienced decreased appetite. It was reported that after second dose, the patient felt fine the next day until 1:00 pm and each day since. At 1:00 pm must lie down and rest for at least one hour. The patient had limited appetite for various foods which she usually eat, duration and intensity of these episodes is lessening (today was day 4 post inoculation) but still happened today. The patient did not received treatment for event. The patient was recovering from the event.

Other Meds:

Current Illness:

ID: 1652042
Sex: F
Age:
State: MS

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 202103; Test Name: Left Breast Exam; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: left side under my arm and side of my left breast was painful and tender.; left side under my arm and side of my left breast was painful and tender.; could hardly lift my left arm; could feel lumps the size of an egg near my left breast and under left arm as well as inside of left side cavity near my left breast; could feel lumps the size of an egg near my left breast and under left arm as well as inside of left side cavity near my left breast; This is a spontaneous report from a contactable consumer (patient reported for self). A 44-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 26Mar2021 (at the age of 44-years-old) as dose 2, single for COVID-19 immunisation. (Reason why batch/lot is Unknown: Not available/provided to reporter at the time of report completion). Medical history included diabetes mellitus from an unknown date and unknown if ongoing; Known allergies: Mucinex DM patient previously took Mucinex DM and experienced drug hypersensitivity. Patient had earlier received first dose of BT162b2 for covid-19 immunisation on 05Mar2021 9:30 (at the age of 44-years-old) on arm left as dose 1, single for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication (other medications the patient received within 2 weeks of vaccination) included Semaglutide (OZEMPIC) shot once a week and Ascorbic Acid (VITAMIIN C) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient reported stating on 27Mar2021 09:00 "A day after receiving Pfizer's second dose the left side under my arm and side of my left breast was painful and tender. I could hardly lift my left arm. Left Breast was painful and sore feeling. I could feel lumps the size of an egg near my left breast and under left arm as well as inside of left side cavity near my left breast." The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included Left Breast Exam (breast scan): unknown results on an unspecified date in Mar2021. Diagnostic Left Breast Exam was taken as treatment for all the events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was recovered with sequelae. Device Date : 19May2021. Follow-up (16Jul2021): Follow-up attempts completed. No further information expected.

Other Meds: OZEMPIC; VITAMIIN C

Current Illness:

ID: 1652043
Sex: M
Age:
State: NC

Vax Date: 04/28/2021
Onset Date: 04/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Left arm and side had numbness sensation for 3 days then went away, no other side affects; Left arm and side had numbness sensation for 3 days then went away, no other side affects; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0151, Expiration date were not reported) via an unspecified route of administration, administered on arm left on 28Apr2021 at 10:00 (age at vaccination was 40 years) as dose 1, single for COVID-19 immunization workplace clinic. No other vaccine in four weeks. On 28Apr2021 at 11:00 the patient developed Left arm and side had numbness sensation for 3 days then went away, no other side effects. No covid prior vaccination. No covid was tested post vaccination. No allergies were reported. No other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was recovered on an unspecified date 2021. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1652044
Sex: F
Age:
State: TX

Vax Date: 05/18/2021
Onset Date: 05/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Drowsiness; Joint pain in left thigh; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the right arm on 18May2021 at 16:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 27Apr2021 at 16:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19May2021 at 05:00, the patient experienced joint pain in left thigh, drowsiness. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events joint pain in left thigh, drowsiness was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness: Penicillin allergy

ID: 1652045
Sex: F
Age:
State: FL

Vax Date: 05/17/2021
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Body body aches; Body discomfort; Pain in armpit; Extreme tiredness; Fever; Headache; Pain in arm; This is a spontaneous report from a contactable consumer (patient). A 24-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 17May2021 (age at the time of vaccination 24-years-old, patient was not pregnant at the time of vaccination), as DOSE 2, SINGLE for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medication included birth control medication. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a DOSE 1, SINGLE for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced extreme tiredness, body aches, fever, headache, pain in armpit, pain in arm and body discomfort on 18May2021. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events was recovering at the time of this report. The lot number for the vaccine (PFIZER-BIONTECH COVID-19 mRNA VACCINE) was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652046
Sex: F
Age:
State: GA

Vax Date: 05/01/2021
Onset Date: 05/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Covid-19 test; Test Result: Positive

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: I notice red itchy bumps on my neck, chest, stomach, back and legs; I notice red itchy bumps on my neck, chest, stomach, back and legs; Hives and dry patches of skin; Hives and dry patches of skin; This is a spontaneous report from a contactable other healthcare professional. A 61-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on an unspecified date in May2021 (Batch/Lot number and Expiry date was not reported) (at the age of 61-years-old) as DOSE 1, SINGLE for covid-19 immunization. Medical history included covid-19 (Prior to vaccination, the patient was diagnosed with COVID-19). Concomitant medications included vitamins nos (DAILY VITAMINS), ascorbic acid (VIT C), Coq 10 and cholecalciferol (COLECALCIFEROL) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19 and Since the vaccination, the patient has not been tested for COVID-19. On 04May2021 11:00, the patient experienced i notice red itchy bumps on my neck, chest, stomach, back and legs, hives and dry patches of skin. It was reported as Three days after the patient received the vaccine, she noticed red itchy bumps on her neck, chest, stomach, back and legs and they began to increase in number in the days following. She went to the clinic at the withheld Pharmacy where she got the vaccine and was prescribed a prednisone pack to take over 6 days. When she has completed the pack, the red bumps returned along with hives and dry patches of skin. She further stated that she was trying to decide whether to get the 2nd dose. Laboratory tests on an unspecified date included sars-cov-2 test: positive. The patient received treatment with prednisone. The clinical outcome of the events was not recovered. Follow-up attempts completed. No further information is expected.

Other Meds: DAILY VITAMINS; VIT C; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 1652047
Sex: F
Age:
State: NY

Vax Date: 05/17/2021
Onset Date: 05/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210518; Test Name: Temperature; Result Unstructured Data: Test Result:101.2 Fahrenheit; Comments: at 10:26; Test Date: 20210518; Test Name: Temperature; Result Unstructured Data: Test Result:101.2 Fahrenheit; Comments: She took temperature right after; Test Date: 20210519; Test Name: Temperature; Result Unstructured Data: Test Result:100.2 Fahrenheit; Comments: at 13:20; Test Date: 20210519; Test Name: Temperature; Result Unstructured Data: Test Result:100.2 Fahrenheit; Comments: She took temperature right after; Test Name: Pulse; Result Unstructured Data: Test Result:100/106

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: developed a fever; Soreness in neck and shoulders both sides; Soreness in neck and shoulders both sides; body soreness; Soreness left upper arm/ soreness all over upper part of arm where she got vaccine; This is a spontaneous report from a contactable consumer (patient). A 62-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EW0167, Expiry date: not reported), via an unspecified route of administration in left arm on 17May2021 11:00 (at age of 62-years-old) as dose 1, single for covid-19 immunization in hospital. Medical history included ongoing diabetes mellitus Onset Date: Had for maybe 20 years , ongoing glaucoma Onset Date: Had for about 15 years , covid-19 (developed in lungs, was on antibiotic for 2 weeks, breathing not right) from 23Mar2021 to an unknown date Stop Date: Resolved, unknown date. Family medical history relevant to adverse event were none. Concomitant medication(s) included metformin hydrochloride, sitagliptin phosphate (JANUMET LONG) taken for diabetes mellitus from an unspecified start date and ongoing; glimepiride (GLIMEPIRIDE) taken for diabetes mellitus, start and stop date were not reported; latanoprost (LATANOPROST) taken for glaucoma from an unspecified start date and ongoing. The patient had not received any other vaccine within 4 weeks. On 17May2021 at 20:00, the patient experienced soreness left upper arm, soreness all over upper part of arm where she got vaccine and body soreness. On 18May2021, the patient developed a fever (at 10:26) and soreness in neck and shoulders both sides. Consumer stated she developed a fever on 18May2021, with a temperature of 101.2 Fahrenheit. Caller took her temperature a little while ago and it was 100.2 Fahrenheit. Caller stated those were temperature readings after she had taken Tylenol. Caller was wondering if that was normal and if she should seek medical attention. Caller was also asking how long her symptoms might last. The patient took bnt162b2 vaccine as she works with public, mother was elderly, hesitant to get it, wants to get back to normal. The patient had been having low-grade fever ever since. The patient had arm soreness that went away and body soreness. The patient was taking Tylenol. The patient had low-grade fever ever since and wanted to know what was going on. The patient remarked she had paper with common side effects, but wants to know if that was normal. Caller clarified she had soreness all over upper part of arm where she got vaccine. Soreness in arm went away. Caller said the soreness was in the left arm. Then caller clarified that left arm was still a little tender to touch where she had the injection. Soreness in arm started the evening of the shot. She said she could lift her arm now. Caller then added that she had soreness in back of neck where shoulders are on both left and right side. Soreness in shoulders started in the evening. Caller stated she took her temperature on 18May2021 at 10:26 confirmed temperature of 101.2 degrees. The patient took temperature right after and it was also 101.2 degrees. Caller said she took her pulse and it was 100/106 on an unspecified date. Attempted to clarify several times with caller that pulse was 100/106 and she stated pulse was 100/106. Caller took temperature on day of reporting at 13:20 and it was 100.2 degrees. She took temperature twice and second time was also 100.2 degrees. No history of all previous immunization with the bnt162b2 vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). Additional vaccines administered on same date of the bnt162b2 suspect were none. Adverse events following prior vaccinations were reported as none. The adverse event did not required visit to emergency room or visit to physician's office. Treatment included tylenol for soreness in left arm and shoulders and low-grade fever. The patient underwent lab tests and procedures which included body temperature increased: 101.2 fahrenheit, body temperature increased: 101.2 fahrenheit on 18May2021, body temperature increased: 100.2 fahrenheit on 19May2021, body temperature increased: 100.2 fahrenheit on 19May2021 and heart rate: 100/106 on an unspecified date. Therapeutic measures were taken as a result of soreness in left arm and shoulders and fever. The outcome of the event soreness all over upper part of arm where she got vaccine was not recovered and outcome of rest of the events was unknown. Information on Lot/Batch number was available. Additional information has been requested. Follow-up attempts completed. No further information expected.

Other Meds: JANUMET LONG; GLIMEPIRIDE; LATANOPROST

Current Illness: Diabetes (Onset Date: Had for maybe 20 years); Glaucoma (Onset Date: Had for about 15 years)

ID: 1652048
Sex: F
Age:
State: MI

Vax Date: 05/11/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Hot flashes; Abdominal pain; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0172) via an unspecified route of administration in the left arm on 11May2021 at 13:00(at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history were not reported. The patient did not receive any medication within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 06:00, the patient experienced fatigue, chills, hot flashes and abdominal pain. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events fatigue, chills, hot flashes and abdominal pain was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652049
Sex: F
Age:
State:

Vax Date: 05/07/2021
Onset Date: 05/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Mouth was numb; At 17 hours I broke out into hives all over my body, including my mouth; After 13 hours, I had chills; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 07May2021 at 13:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. No relevant medical history. The patient only had a prior allergic reaction to airborne. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 15Apr2021 at 15:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08May2021 at 02:00 the patient had chills after 13 hours and at 15 hours, the patient received Tylenol. At 17 hours, the patient broke out into hives all over body, including mouth at 06:00 . Mouth was numb and the hives were large enough that patient could not speak comfortably. The patient took Benadryl at 17 hours. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of chills which included treatment with Tylenol and hives and Mouth was numb which included treatment with Benadryl. The clinical outcome of the event hives was resolved on 08May2021 at 10:00. The clinical outcome of the mouth was numb was recovered on 08May2021. The clinical outcome of chills was recovered on an unknown date in May2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652050
Sex: F
Age:
State: NJ

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Numbness in right foot toes/Had similar sensation in left toes but to much losses extent; Tingling in right foot toes/Had similar sensation in left toes but to much losses extent; Short episode of disequilibrium; This is a spontaneous report from a contactable physician. A 49-years-old female Physician reported for herself that who received second dose of BNT162B2 (BNT162B2, solution for injection), intramuscular, administered in Vastus Lateral Right on 28Jan2021 15:55 (Batch/Lot Number: EL9262) (at the age of 49-years-old) as SINGLE for covid-19 immunization and was administered at hospital. Medical history included ongoing menstrual cycle management, ongoing general symptom, ongoing UCTD (undifferentiated connective tissue disease). Concomitant medication (received within 2 weeks of vaccination) included hydroxychloroquine sulfate (PLAQUENIL) at 300mg daily oral for undifferentiated connective tissue disorder, methotrexate at 2.5mg weekly oral for undifferentiated connective tissue disorder, mycophenolate mofetil (CELLCEPT) at 750mg twice a day oral for undifferentiated connective tissue disorder, folic acid daily and magnesium, ergocalciferol (VIT D) 5000 IU/week oral for general health, vitamin B complex (VITAMIN B) daily, vitamins magnesium 400mg daily oral for general health, multivitamin 2-3 times per week oral and oral contraceptive for cycle control 1 tab daily oral. The patient historical vaccine included received first dose of BNT162B2 (BNT162B2, solution for injection), intramuscular, administered in Deltoid left on 07Jan2021 15:55 (Batch/Lot Number: EK9231) as SINGLE for covid-19 immunization and experienced disequilibrium, left side of my face felt heavy, stiff, and was palpably warmer than the right side of my face, awoken by intense bilateral leg pain, left deltoid with prickly "itchy" sensation. Approximately one hour after second vaccine given on 28Jan2021, short episode of disequilibrium occurred, followed by numbness and tingling in right foot toes which lasted approximately 30 minutes. Had similar sensation in left toes but to much losses extent. The outcome of events was recovered on 28Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds: CELLCEPT [MYCOPHENOLATE MOFETIL HYDROCHLORIDE]; MAGNESIUM; METHOTREXATE; PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]

Current Illness: General symptom; Menstrual cycle management (Concomitant medication name: Oral contraceptive Indication: Cycle control); Undifferentiated connective tissue disease

ID: 1652051
Sex: F
Age:
State: HI

Vax Date: 05/05/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Palmar digital vein thrombosis on my left index finger of the second digit; This is a spontaneous report from a contactable consumer (patient). This 58-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0173) via an unspecified route of administration on 05May2021 at 08:30 (at the age of 58-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included high blood pressure and allergy to pollen. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included amlodipine from an unknown date for an unknown indication. On 12May2021 the patient experienced palmar digital vein thrombosis on her left index finger of the second digit. The event was reported as non-serious. The patient was not hospitalized for the event. The patient visited a doctor or other healthcare professional office/clinic as a result of the event. The patient did not receive treatment for the event. The outcome of palmar digital vein thrombosis was not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.

Other Meds: AMLODIPINE

Current Illness:

ID: 1652052
Sex: F
Age:
State: OR

Vax Date: 05/15/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Large, red patchy area around vaccine site.; Very enlarged lymph node in left armpit; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 15May2021 at 11:15 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included quetiapine (MANUFACTURER UNKNOWN), zolpidem (MANUFACTURER UNKNOWN) and prazosin (MANUFACTURER UNKNOWN) all taken for unknown indication from an unknown date, taken within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 24Apr2021 at 15:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16May2021, the patient experienced Large, red patchy area around vaccine site, very enlarged lymph node in left arm pit. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The clinical outcome of the events Large, red patchy area around vaccine site, very enlarged lymph node in left arm pit were resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: QUETIAPINE; ZOLPIDEM; PRAZOSIN

Current Illness:

ID: 1652053
Sex: F
Age:
State: FL

Vax Date: 05/18/2021
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Headache; This is a spontaneous report from a contactable consumer, the patient. A 15-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 18May2021 at 13:30 (at the age of 15-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. The patient did not receive any medication within two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18May2021 at 20:00, the patient experienced headache. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event which included treatment Tylenol. The clinical outcome of the event headache was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652054
Sex: F
Age:
State: TX

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Irregular (extra) and heavy periods; Irregular (extra) and heavy periods; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 44-year-old (non-pregnant) female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER8731) via an unspecified route of administration, administered in arm left on 22Apr2021 13:00 (at the age of 44-year-old) at dose 2, single for covid-19 immunisation. Medical history included depression from an unknown date and unknown if ongoing. Patient had no Known allergies. Patient did not have covid prior vaccination. Patient has not tested for covid post vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medication included cetirizine hydrochloride (ZYRTEC ALLERGY); lamotrigine (LAMICTAL); sertraline hydrochloride (ZOLOFT); lithium (LITHIUM), all the drugs taken for an unspecified indication, start and stop date were not reported (other medications in two weeks). Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EP6955) via an unspecified route of administration, administered in arm left on 25Mar2021 13:00 (at the age of 44-year-old) at dose 1, single for covid-19 immunisation. On 23Apr2021 the patient experienced irregular (extra) and heavy periods. Patient did not receive treatment for the adverse events. Outcome of the events was not resolved. Follow-up (16Jul2021): Follow-up attempts completed. No further information expected.

Other Meds: ZYRTEC ALLERGY; LAMICTAL; ZOLOFT; LITHIUM

Current Illness:

ID: 1652055
Sex: F
Age:
State: IN

Vax Date: 04/30/2021
Onset Date: 05/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202105; Test Name: Nasal Swab; Test Result: Negative.

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Pt developed erythematous macular rash across torso approx 1-1.5wks after the 2nd dose of vaccination; This is a spontaneous report from a contactable physician. A 37-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 2 intramuscular, administered in Arm Left on 30Apr2021 (at the age of 37-years-old) as a single dose for covid-19 immunization. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 1 via an unspecified route of administration on 09Apr2021 (at the age of 37-years-old) as a single dose for covid-19 immunization. Medical history included hypothyroidism, depression, hyperlipidemia. Concomitant medication(s) and received within 2 weeks of vaccination included atorvastatin, SYNTHROID, PAXIL, ORTHO TRI-CYCLEN. The patient had allergies with metaclazepam drug hypersensitivity. The patient had no other vaccine within four weeks. On 10May2021, the patient experienced erythematous macular rash across torso approximately 1-1.5wks after the 2nd dose of vaccination. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included nasal swab, sars-cov-2 test negative on May2021. The patient received treatment for the adverse event with betamethasone cream topically. Outcome of the event was not recovered. Device Date was 19May2021. Information regarding the lot/batch number has been requested. No new information was received.

Other Meds: ATORVASTATIN; SYNTHROID; ORTHO TRI-CYCLEN; PAXIL

Current Illness:

ID: 1652056
Sex: F
Age:
State:

Vax Date: 05/17/2021
Onset Date: 05/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Rash; hives over ears, face, neck, chest, and arm of injection at two hours; coughing; shortness of breath; This is a spontaneous report from a non-contactable consumer (patient). A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 17May2021 10:00 (Batch/Lot Number: EWO171) (at the age of 44 years old) as dose 1, single for COVID-19 immunisation. Medical history included asthma, migraines, allergy to latex, possible food allergies and allergy to sulfa. Concomitant medications included loratadine, pseudoephedrine sulfate (CLARITIN-D) taken for an unspecified indication, start and stop date were not reported; montelukast sodium (SINGULAIR) taken for an unspecified indication, start and stop date were not reported; and ibuprofen (ADVIL [IBUPROFEN]) taken for an unspecified indication, start and stop date were not reported. The patient previously took fluoride and experienced drug allergy. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 17May2021 12:00, the patient experienced rash, hives over ears, face, neck, chest, and arm of injection at two hours, then coughing and shortness of breath not responding to asthma medicine. The adverse event resulted in any Doctor or other healthcare professional office/clinic visit. Treatment was given for the events including stronger asthma inhaler and epi-pen prescription. Prior to vaccination, it was unknown if the patient diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The reporter assessed the case as non-serious and no hospitalization. The outcome of the events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: CLARITIN-D; SINGULAIR; ADVIL [IBUPROFEN]

Current Illness:

ID: 1652057
Sex: M
Age:
State:

Vax Date: 05/12/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210512; Test Name: temperature; Result Unstructured Data: Test Result:101- 102 Fahrenheit; Comments: the first 4 days, he "had temperature of 101-102?F

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: nausea; vomiting; upper back & lower back pain/I have back pain; I have on back I have very sharp pain in my lower back and in my back; I cannot sit for long period, I have to lay down; temperature of 101-102?F/I had high temperature of 101; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 35-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 via an unspecified route of administration on 12May2021 (at the age of 35-year-old) (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. Medical history included covid-19 from Aug2020, to an unknown date. The patient concomitant medications were not reported. On 12May2021, the patient experienced temperature of 101-102 degree Fahrenheit. The patient had high temperature of 101. On 17May2021, nausea, vomiting and back pain on back very sharp pain in lower back and in back; patient cannot sit for long period to lay down. Consumer reported the patient took the Pfizer shot (Pfizer Covid vaccine) a week ago on Wednesday (confirmed as 12 May 2021), 8 days ago, he had this reaction. He took it 8 days ago on the first day on the first he had high temperature of 101 and then he had back pain, nausea and vomiting for the 5th, 6th, 7th, 8th day he had on back and very sharp pain in his lower back and in his back and he cannot sit for long period, he had to lay down so he just, why that was and this is his first shot he took, he had Covid back in august, this way I have same feeling. But the back pain, back sharp pain was just too much, he cannot stand it, he spoke with his regular doctor. The patient underwent lab tests and procedures which included body temperature increased: the first 4 days 101- 102 degree Fahrenheit on 12May2021. The clinical outcome of the events were unknown. No follow-up attempts are completed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652058
Sex: F
Age:
State: CA

Vax Date: 05/11/2021
Onset Date: 05/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: The lymph nodes on throat and armpit on the left side (side of injection) started swelling rapidly; High fever; Nausea; Feeling very sick; Bad diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11May2021 at 13:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included lithium (MANUFACTURER UNKNOWN) on unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11May2021 at 11:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 14May2021 at 23:00, the patient experienced the lymph nodes on his throat and armpit on the left side (side of injection) started swelling rapidly. The patient had high fever and nausea. The onset felt very sudden and within one hour the patient was feeling very sick. She took 500mg acetaminophen and also had bad diarrhea Thursday and Friday without any changes in her diet. She was not sure if that was a side effect too. The next day she felt better, and took acetaminophen again. The swelling in her lymph nodes did not fully go away for 3 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with (500mg) acetaminophen. The clinical outcome of the event bad diarrhoea was recovered on 15May2021 after the duration of 2 days. The clinical outcome of the event the lymph nodes on throat and armpit on the left side (side of injection) started swelling rapidly was recovered on 17May2021 after the duration of 3 days. The clinical outcome of the events high fever, nausea and feeling very sick was recovered on unspecified date May2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LITHIUM

Current Illness:

ID: 1652059
Sex: F
Age:
State: CA

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Patient have not had a period since 2nd dose, It was been almost 2 months and still did not have period.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 24Mar2021 at 11:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism (Hashimoto's) for which patient received a low daily dose (0.25mg) of Levothyroxine. The patient had no known allergies to medications, food or other products. Concomitant medication was not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via an unspecified route of administration in the left arm on 02Mar2021 at 14:00 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. The patient previously took levothyroxine for hypothyroidism (Hashimoto's), patient take a low daily dose (.25mg). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Mar2021 the patient received the 2nd dose of Pfizer vaccine on the last day of her last menstrual cycle (March 24th), and she not had a period since. Patient used a tracker app to keep track of her cycle, and she never skipped a period before. The patient was not pregnant, and have not started taking any new medication since receiving the 2nd dose of Pfizer vaccine that would affect her period. That has been almost 2 months and patient still did not had her period. Therapeutic measures were not taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events she not had a period since, has been almost 2 months and patient still did not had her period was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652060
Sex: F
Age:
State: TN

Vax Date: 05/11/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Sore left arm -whole arm; Metallic taste in mouth; Body aches especially upper shoulder and back area; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 11May2021 at 13:30 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease, dupuytren's contracture, attention deficit-hyperactivity disorder (ADHD) and osteopenia. Concomitant medications included levothyroxine sodium (TIROSINT) 88 mcg, liothyronine (MANUFACTURER UNKNOWN) 5 mcg and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) 25mg twice daily from an unknown date and unknown if ongoing for unknown indications. The patient previously took codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 09:00, the patient experienced sore left arm -whole arm, metallic taste in mouth and body aches especially upper shoulder and back area. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore left arm -whole arm, metallic taste in mouth and body aches especially upper shoulder and back area was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TIROSINT; LIOTHYRONINE; ADDERALL

Current Illness:

ID: 1652061
Sex: F
Age:
State:

Vax Date: 05/17/2021
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Stomach cramps; Gas pains; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17May2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included adhd and allergy to chicken. Concomitant medications included ethinylestradiol, etonogestrel (NUVARING) and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); both from unknown start dates and for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 18May2021, the patient experienced stomach cramps and gas pains. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events stomach cramps and gas pains were not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: NUVARING; ADDERALL

Current Illness:

ID: 1652062
Sex: F
Age:
State: KS

Vax Date: 05/17/2021
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Large red and raised spot at injection site. Growing hotter and bigger daily; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 17May2021 at 13:30 (at the age of 36-year-old) as a single dose for COVID-19immunisation. Medical history and concomitant medications were not reported. The patient previously took penicillin (MANUFACTURER UNKNOWN), ketorolac tromethamine (TORADOL) and prochlorperazine edisylate (COMPAZINE) for unknown indication on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18May2021 the patient experienced large red and raised spot at injection site, growing hotter and bigger daily. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event large red and raised spot at injection site, growing hotter and bigger daily was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652063
Sex: M
Age:
State: PA

Vax Date: 05/15/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: sore arm; left arm pit lymph nodes swollen with pain; left arm pit lymph nodes swollen with pain; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 15May2021 at 10:00 (at the age of 13-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Concomitant medication included multivitamins (MANUFACTURER UNKNOWN) from an unknown date and unknown if ongoing for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 10:15 the patient experienced sore arm. On an unknown date in May2021 the patient experienced left armpit lymph nodes swollen with pain. Therapeutic measures were not taken as a result of the events sore arm and left armpit lymph nodes swollen with pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sore arm and left armpit lymph nodes swollen with pain was resolved on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652064
Sex: F
Age:
State: VA

Vax Date: 04/13/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Inappropriate schedule of vaccine administered; After second dose experiencing phantosmia. Smelling very bad odors that don't exist; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8737) via an unspecified route of administration in the right arm on 13Apr2021 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medication included eszopiclone (LUNESTA) from an unknown date for an unknown indication and unknown if its ongoing. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP6955) via an unspecified route of administration in the right arm on 20Feb2021 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021, after second dose, the patient experienced phantosmia. Smelling very bad odors that don't exist. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event phantosmia was not recovered/not resolved/ongoing. No follow-up attempts are possible. No further information is expected.

Other Meds: LUNESTA

Current Illness:

ID: 1652065
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: stabbing pain in right ear/ intermittent ear pain; loud ringing in right ear; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient did not have a history of allergies to any food or medications or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unknown date, 7 hours after receiving the vaccine the patient woke up from a deep sleep with a stabbing pain in right ear and loud ringing in right ear and six weeks later, the patient still have ringing in ears, pain in ear was slowly going away and had intermittent ear pain. Since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with an unspecified medication. The clinical outcome of the events a stabbing pain in right ear/ intermittent ear pain and loud ringing in right ear was recovered with sequelae on an unknown date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652066
Sex: F
Age:
State: MA

Vax Date: 05/17/2021
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: large lump at vaccination site on left arm, red, hot, itchy and painful to touch; large lump at vaccination site on left arm, red, hot, itchy and painful to touch; large lump at vaccination site on left arm, red, hot, itchy and painful to touch; large lump at vaccination site on left arm, red, hot, itchy and painful to touch; large lump at vaccination site on left arm, red, hot, itchy and painful to touch; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0167) via an unspecified route of administration in the left arm on 17May2021 at 14:45(at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient had no allergy to food, medication or other products. The patient did not receive any other medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0176) via an unspecified route of administration in the left arm on 26Apr2021 at 15:00(at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 18May2021 at 00:00, the patient experienced large lump at vaccination site on left arm, red, hot, itchy and painful to touch. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent. The clinical outcome of large lump at vaccination site on left arm, red, hot, itchy and painful to touch were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652067
Sex: F
Age:
State: ID

Vax Date: 05/19/2021
Onset Date: 05/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Very sore upper arm; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 19May2021 at 14:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included zolpidem tartrate (AMBIEN), fluoxetine hydrochloride (PROZAC), cefdinir (MANUFACTURER UNKNOWN) and colecalciferol (5000International Units) (VITAMIN D3), all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20May2021 at 04:30, the patient experienced very sore upper arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event very sore upper arm was resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMBIEN; PROZAC; CEFDINIR; VITAMIN D3

Current Illness:

ID: 1652068
Sex: M
Age:
State: TX

Vax Date: 03/17/2021
Onset Date: 03/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: My right foot also got tendonitis which I have never gotten before; Periodic numbness in leg; Abnormal bruising/entire wrist area bruised; Bump swell up in wrist area and felt a slight burst; Feet just had random pains like muscle pain; I have been having joint pain in my wrists and feet; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 17Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to sun flower seeds. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on 24Feb2021 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccination. On an unknown date in Mar2021, the patient had been having joint pain in wrists, and feet, and periodic numbness in leg, as well as abnormal bruising, a few weeks back (unspecified date), in the middle of the night, the patient felt a bump swell up in his wrist area, and felt a slight burst, and the next day his entire wrist area was bruised. The patient felt that he was more easily bruised than normal. The patient wrist still had a pain in it, and his feet just had random pains like muscle pain. The patient right foot also got tendonitis which he had never gotten before, and sometimes if he step wrong, he could feel pain. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events right foot also got tendonitis, periodic numbness in leg, abnormal bruising/entire wrist area bruised, bump swell up in wrist area and felt a slight burst, feet just had random pains like muscle pain and joint pain in wrists and feet was resolved with sequelae, with lasting effects on an unknown date in 2021. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652069
Sex: M
Age:
State: CT

Vax Date: 05/17/2021
Onset Date: 05/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Fever; chills; body aches; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the left arm on 17May2021 at 00:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was having stone fruit allergy. The patient did not receive any concomitant medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17May2021 at 21:00, the patient experienced fever, chills and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of the events fever, chills and body aches were recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652070
Sex: F
Age:
State: GA

Vax Date: 05/18/2021
Onset Date: 05/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Left underarm (arm pit) swollen; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN603) via an unspecified route of administration in the left arm on 18May2021 at 09:30 AM (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and penicillin allergy. The patient previously took Tamiflu and experienced allergy to it. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. On 19May2021 at 13:00, one day after vaccination, the patient experienced left underarm (arm pit) swollen and fatigue. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left underarm (arm pit) swollen and fatigue was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652071
Sex: F
Age:
State: FL

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: Tetracycline

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: This is a spontaneous report from a noncontactable consumer (patient). A 62-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, batch/lot# unknown), at the age of 62, via an unspecified route of administration, left arm, on Apr 7, 2021, at 09:45, single dose, for COVID-19 immunisation. Medical history included asthma, hypothyroidism and pseudocholinesterase deficiency. Concomitant medications included levothyroxine from an unknown date and for an unknown indication. The patient previously took tetracycline hydrochloride on an unknown date and experienced allergy. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 7, 2021, at 16:00, patient experienced stuffed nose, fatigue, left arm pain, swelling, swollen lymph nodes (opposite arm), breast rash (opposite-side) and trouble breathing. The adverse events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures taken as a result of reported events included treatment with topical creams, inhalers and ice from unknown dates. The clinical outcome of the events stuffed nose, fatigue, left arm pain and swelling, swollen lymph nodes (opposite-arm), breast rash (opposite-side) and trouble breathing: unknown (at the time of this report). No follow-up attempts possible. Information about lot/batch number cannot be obtained.

Other Meds: Levothyroxine

Current Illness:

ID: 1652072
Sex: F
Age:
State: GA

Vax Date: 03/09/2021
Onset Date: 04/30/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: ultrasound; Result Unstructured Data: Test Result:result not provided

Allergies:

Symptom List: Pain in extremity

Symptoms: I had spotting - like a menstrual cycle. I have been in menopause for 5 years; This is a spontaneous report from a contactable consumer (patient). A 52-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 09Mar2021 (Lot number was not reported) as dose 2, single at 52-years-old for covid-19 immunization at a hospital. Medical history included menopause from an unknown date for 5 years. The patient's concomitant medications include unspecified vitamins and thyroid medications. The patient previously receive the first dose of bnt162b2 on Feb2021 at 10:00 am Left arm at 52-years-old for covid-19 immunization. No known allergies. Not diagnosed with covid-19 prior and not tested post vaccination. Did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Apr2021 13:00, the patient reported that "I had spotting - like a menstrual cycle. I have been in menopause for 5 years so this was shocking." The event resulted in: doctor or other healthcare professional office/clinic visit. The reporter considered the event as non-serious. The patient underwent lab tests and procedures which included ultrasound scan: result not provided on an unspecified date. The patient received an unspecified treatment. The outcome of the event was recovered on an unspecified date in 2021. The lot number for BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652073
Sex: M
Age:
State: CT

Vax Date: 05/20/2021
Onset Date: 05/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Immediate blurred vision; nausea; sweats; This is a spontaneous report from a non-contactable consumer (patient). A 12-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: Unknown), via an unspecified route of administration, administered in left arm on 20May2021 at 10:00 at the age of 12-years-old as dose number unknown, single for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20May2021 at 10:00, the patient experienced immediate blurred vision, nausea and sweats. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events, immediate blurred vision, nausea and sweats were recovering at the time of this report. The lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652074
Sex: F
Age:
State: WI

Vax Date: 05/18/2021
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210408; Test Name: SARS-COV-2 BY RAPID ANTIGEN; Test Result: Negative ; Comments: Nasal swab; Test Date: 20210408; Test Name: SARS COV2 BY PCR; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: cannot eat; tired; nausea; severe headache; total body aches; shortness of breath; severe pain in lower abdomen; severe chills; sweating; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0187), via an unspecified route of administration in right arm on 18May2021 at 14:30 (at the age of 63 years old) as single dose for COVID-19 immunisation. The patient had no medical history. Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had been tested for COVID-19. On 08Apr2021, the patient underwent SARS COV2 by PCR (nasal swab) test and the result was negative. On the same day, the patient underwent SARS-COV-2 by RAPID ANTIGEN (nasal swab) test and the result was negative. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0187), via an unspecified route of administration in right arm on 27Apr2021 at 14:30 (at the age of 62 years old) as single dose for COVID-19 immunisation. On 18May2021 at 14:45, within 20 minutes of vaccination, the patient experienced severe pain in lower abdomen. On the same day, in the night, the patient experienced severe chills and sweating. On 19May2021, the patient was tired, had nausea, severe headache, total body aches and shortness of breath. The patient stated she almost went to emergency room (ER) and patient had to sit upright all night. On 20 May2021, the patient finally got out of bed, but cannot eat and only drank ice water. The events were present event at the time of report and the patient missed work for 4 days and was sure even the next day of report she will not be able to work. Therapeutic measures were not taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event severe pain in lower abdomen, severe chills, sweating, tired, nausea, severe headache, total body aches, shortness of breath and cannot eat were not resolved at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652075
Sex: F
Age:
State: AR

Vax Date: 04/30/2021
Onset Date: 05/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Blisters up and down left and right arms and top of shoulders; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: ER8736), via an unspecified route of administration in the left arm on 30Apr2021 at 10:45 (at the age of 63-year-old), as a single dose for COVID-19 immunisation. Medical history included diabetic type 2 and the patient had known allergies to medications, food, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10May2021, the patient experienced blisters up and down left and right arms and top of shoulders. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event of blisters up and down left and right arms and top of shoulders was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652076
Sex: M
Age:
State: NV

Vax Date: 05/09/2021
Onset Date: 05/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210517; Test Name: Nasal Swab; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Vomiting

Symptoms: Shingles; This is a spontaneous report from a contactable consumer or other non-HCP (patient himself). A 69-year-old male patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09May2021 10:30 (at the age of 69-years-old) as dose 2, single for COVID-19 immunization. Vaccination facility type was reported as Pharmacy or Drug Store. Patient medical history included high cholesterol and known allergies to chestnuts. The patient previously received simvastatin for high cholesterol from unknown date. The patient previously received varicella zoster vaccine (shingles vaccine) on an unspecified date in 2018. Historical vaccine received the BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number- EW171) via an unspecified route of administration in left arm on 18r2021 10:30 as dose 1, single for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11May2021 at 22:00, 2 days after the second vaccine, the patient experienced a series of red dots appeared in a triangular pattern on 2 parts of upper right thigh. The patient dermatologist diagnosed it as Shingles. The patient had the shingles vaccine in 2018, hence was surprised by this side effect. The patient underwent lab tests and procedures which included Sars-Cov-2 (nasal swab) test for COVID-19 on 17May2021 and tested negative. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles and included treatment with valacyclovir. The clinical outcome of the event shingles was not recovered at the time of this report. The lot number for the vaccine, [BNT162b2], was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652077
Sex: M
Age:
State: CA

Vax Date: 05/05/2021
Onset Date: 05/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Insomnia; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 05May2021 at 12:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications included oral antibiotics from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 10May2021, the patient experienced insomnia. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of insomnia was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652078
Sex: F
Age:
State: NJ

Vax Date: 05/18/2021
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Fog like feeling; lightheadedness; Decrease in appetite; Vomiting; Severe migraine; Dizziness; Tightness of sinuses; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in the left arm on 18May2021 at 13:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to latex, watermelon and seafood. Concomitant medications included fluoxetine hydrochloride (PROZAC), aluminium hydroxide, magnesium trisilicate, sodium alginate (PEPCID) and gliclazide (CLARITIN), all taken for unspecified indications from unknown dates. The patient previously took bactrim, macrobid, ciprofloxacin and monistat and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18May2021 at 22:45, the patient experienced severe migraine with dizziness and tightness of sinuses. On 19May2021, the next morning, the patient experienced vomiting twice. On 21May2021, 60 hours after the shot, the patient experienced fog like feeling as well as some lightheadedness and decrease in appetite. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events severe migraine with dizziness, tightness of sinuses, vomiting, fog like feeling, lightheadedness and decrease in appetite were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PROZAC; PEPCID [ALUMINIUM HYDROXIDE;MAGNESIUM TRISILICATE;SODIUM ALGINATE]; CLARITIN [GLICLAZIDE]

Current Illness:

ID: 1652079
Sex: F
Age:
State: NC

Vax Date: 05/19/2021
Onset Date: 05/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Severe lower back and bone pain. Sever Left elbow joint pain.; Severe lower back and bone pain. Sever Left elbow joint pain.; Severe lower back and bone pain. Sever Left elbow joint pain.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19May2021 at 09:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patients other medical history was reported as no. The patient had no known allergies to medications, food, or other products. The patient received other medication within two weeks prior to vaccination which included Prenatal (unspecified) from unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 09:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20May2021 at 02:00, the patient experienced severe lower back and bone pain. The patient also experienced severe left elbow joint pain on 20May2021 at 02:00. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events severe lower back and bone pain, severe left elbow joint pain was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652080
Sex: F
Age:
State: NY

Vax Date: 05/11/2021
Onset Date: 05/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Side of left toe had gone numb; Pain in upper back muscles; Slept the first half of the day; Felt like had a major surgery done; Muscles hurt; Hurt to breathe; Dizzy; Fatigued/exhausted; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 11May2021 at 08:45 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. Medical history included borderline personality disorder, degenerative disc disease, have had 2 previous surgeries on L5-S1, also possibly suffered from small fiber neuropathy, fibromyalgia, and/or silent migraines. Concomitant medications included amitriptyline (MANUFACTURER UNKNOWN) and colecalciferol (VITAMIN D3); both for an unspecified indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERE734) via an unspecified route of administration in the left arm on 20Apr2021 at 08:45 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. The patient previously took gabapentin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11May2021, within an hour, the patient experienced sore arm and on 11May2021 by 22:00, the patient felt like she had a major surgery done, all of muscles were hurt, it was even hurting to breathe, felt dizzy and fatigued. On 12May2021, the next day, the patient was exhausted and slept the first half of the day and by the end of the day, at 22:00, the side of her left toe had gone numb and to the day of reporting, the patient could only feel pressure, and the pain in her upper back muscles was awful and had not gone away. The stretching and physical therapy exercises for the back (exercises taught from previous back issues), had not corrected the issue. The pain and numbness did not get better or worse and pain killers had no effect either. The patient was still fatigued. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events sore arm, hurt to breathe, pain in upper back muscles, muscles hurt and side of left toe had gone numb and included treatment with pain killers (unspecified) and stretching and physical therapy exercises. The clinical outcome of the events sore arm, felt like had a major surgery done, hurt to breathe, pain in upper back muscles, dizzy, muscles hurt, fatigued/exhausted, slept the first half of the day and side of left toe had gone numb were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMITRIPTYLINE; VITAMIN D3

Current Illness:

ID: 1652081
Sex: F
Age:
State: IA

Vax Date: 05/10/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Tinnitus in right ear.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10May2021 at 08:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included micrographically oriented histographic surgery (Mohs surgery on face). The patient previously received silicone (MANUFACTURER UNKNOWN) on an unspecified date for an unspecified indication and experienced drug allergy. The patient took unspecified medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12May2021, the patient experienced tinnitus in right ear. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse event. The clinical outcome of the event tinnitus in right ear was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am